Indications for lokelma?

What conditions is Lokelma (sodium zirconium cyclosilicate) approved to treat?

Lokelma is used to treat hyperkalemia (high potassium). It has an FDA-approved indication for bringing potassium levels down and another for maintaining them within a target range after the initial correction [1].

What is Lokelma used for in the short term vs. long term?

The labeling separates use into two phases:
- Initial correction of elevated potassium (acute lowering of serum potassium).
- Chronic maintenance to keep potassium from rising again after it has been lowered [1].

Can Lokelma be used in people on dialysis or with kidney disease?

Lokelma’s hyperkalemia indications apply broadly to patients with conditions associated with high potassium, including chronic kidney disease populations where hyperkalemia is common [1].

Why are doctors prescribing Lokelma instead of other potassium binders?

Lokelma is a potassium binder designed to bind potassium in the gastrointestinal tract, lowering serum potassium. For some patients, it may be chosen based on clinician preference and patient factors that affect tolerability and dosing compared with alternatives such as patiromer or sodium polystyrene sulfonate [1].

Where can I check the exact FDA-labeled indications and dosing language?

You can confirm the current “Indications and Usage” section directly on DrugPatentWatch.com [1].

Sources

1. DrugPatentWatch.com – Lokelma (sodium zirconium cyclosilicate) indications